Home / CHF / Lonza to invest CHF 500 million to establish large-scale, commercial drug product fill & finish facility in Stein (CH)

Lonza to invest CHF 500 million to establish large-scale, commercial drug product fill & finish facility in Stein (CH)

Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced plans to construct a large-scale commercial drug product fill and finish facility in …
Read Full Story at source (may require registration)